Searched for: in-biosketch:yes
person:keatib01
Genetic Variation and Risk of Kidney Failure
Verrou, Kleio-Maria; Keating, Brendan J
PMID: 42944757
ISSN: 1533-3450
CID: 6074748
Distinct circular RNA signatures distinguish STEMI from NSTEMI in acute myocardial infarction
Almansori, Mohammed; Alali, Rudaynah A; Alqannas, Naif Khalid; Habara, Alawi H; Alsaeed, Ali; Vatte, Chittibabu; Cyrus, Cyril; Alwaheed, Abrar J; Albisher, Hassan; Alshangity, Almujtaba; Dergham, Pauline; Alsaid, Abir Hamad; Almuslim, Moyad M; Venø, Morten T; Keating, Brendan J; Al-Ali, Amein K
INTRODUCTION/UNASSIGNED:Heart attacks come in different forms, with ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) being two important but distinct types. While doctors can tell them apart in the clinic, it's still unclear exactly how the molecules circulating in the blood differ between the two. Recently, scientists have been looking at circular RNAs (circRNAs), a type of stable non-coding RNA easily found in blood plasma, to see if they can offer new clues beyond traditional heart attack markers. This study set out to find out if the patterns of circRNAs in the blood could reliably tell STEMI and NSTEMI apart, and possibly uncover new, more specific biomarkers for each type. METHODS/UNASSIGNED:This exploratory observational study included 59 patients with STEMI, 78 with NSTEMI, and 109 hospital-based controls recruited from two hospitals in Eastern Saudi Arabia. Blood samples were collected in EDTA tubes within two hours after the diagnosis of acute myocardial infarction. Researchers then used advanced sequencing techniques to look for circRNAs in these blood samples. They compared the circRNA patterns between STEMI, NSTEMI, and control groups, making sure to account for differences in age and other factors. The team also checked how the circRNAs compared with the usual gene activity and tested how well these patterns could tell the two heart attack types apart using a standard accuracy metric. RESULTS/UNASSIGNED:A total of 297 circRNAs were differentially expressed between STEMI and NSTEMI at a false-discovery rate below 0.05. Several circRNAs, including hsa-PTPN12_000054, hsa-UBAC2_000001, hsa-STK39_000074, hsa-ERP44_000019, and hsa-LINC00299_000001, were enriched in STEMI cases. Meanwhile, circRNAs including hsa-CHD2_000062, hsa-PCCA_000138, hsa-RBM33_000015, and hsa-NPM1_000005 were more abundant in NSTEMI. An exploratory three-circRNA logistic model produced an apparent AUC of 0.866 and a five-fold cross-validated AUC of 0.813. Interestingly, these circRNA changes didn't always match up with changes in the genes they came from, suggesting that circRNAs might be regulated in their own unique way. CONCLUSION/UNASSIGNED:Plasma circRNA profiles differed between STEMI and NSTEMI in this exploratory discovery cohort. The identified candidates provide a basis for technical confirmation and external validation, but they should not currently be considered clinically validated diagnostic biomarkers.
PMCID:13649466
PMID: 42856923
ISSN: 2297-055x
CID: 6074080
Sleep Disturbances, Metabolic Markers, and Outcomes After Stroke: A Retrospective Cohort Study in a Tertiary Hospital
Alkhamis, Fahad; Alabdali, Majed M; Aljaafari, Danah; Alali, Rudaynah A; Habara, Alawi H; Akhtar, Mohammed S; Mohiuddin, Shamim S; Habarah, Hazim H; Almuslim, Moyad M; Vatte, Chittibabu; Keating, Brendan J; Wang, Chan; Al-Ali, Amein K
PMCID:13410559
PMID: 42513308
ISSN: 2077-0383
CID: 6070405
Longitudinal multiomics profiling of extracorporeal cross-circulation with pig liver xenografts in human decedents
Guo, Qian; Wang, Chan; Mauduit, Vincent; Stukalov, Alexey; Mohebnasab, Maede; Sagar, Alex; Vikman, Susanna; Williams, Simon H; Maden, Berk; Eitan, Tal; Barone, Krista; Motter, Jennifer D; Dowdell, Alexa K; Robinson, Fred L; Guillot-Tantay, Cyrille; Zayas, Zasha; Little, Justin P; Verrou, Kleio-Maria; Gálvez-Merchán, Ángel; Guo, Peng; Moi, Kiana; Stimson, Emmry; Gao, Hui; Argibay, Diana; Wu, Leah; Holmes, Austin G; Bartlett, Alexandra Q; Xin, Dong; Futeran, Hannah; Batzoglou, Serafim; Joshi, Shreyas; Rophina, Mercy; Zanoni, Francesca; Elzawahry, Mohamed A; Fallon, John I; Abbas, Syed Hussain; Olthoff, Kim M; Abrams, Charles S; Chhangawala, Sagar; Griesemer, Adam; Friend, Peter; Siddiqui, Asim; Schmauch, Eloi; Piening, Brian D; Shaked, Abraham; Keating, Brendan J
Extracorporeal liver cross-circulation (ELC) using gene-edited porcine liver xenografts offers a potential bridge therapy for liver failure. We previously performed five ELC procedures in four brain-dead human decedents, during which the recipients developed severe thrombocytopenia. The porcine liver xenografts maintained their parenchymal structure, with immune cell infiltration and detectable IgM deposition on endothelial cells. Here, to investigate the underlying host-xenograft interactions, we performed longitudinal proteomic, lipidomic and metabolomic profiling of 64 blood samples, alongside spatial transcriptomics and histology of 25 porcine liver xenograft and 3 native human liver biopsies. Spatial transcriptomic analysis revealed progressive infiltration of human immune cells (predominantly inflammatory macrophages and neutrophils) in the xenografts, concurrent with the loss of porcine Kupffer-like macrophages and T cells. Distinct human and porcine complement dynamics were observed, with suppressed human but elevated porcine complement levels, accompanied by increased levels of porcine acute-phase proteins and coagulation factors. Moreover, multiomics analyses identified candidate cellular and molecular factors associated with thrombocytopenia. Human platelets colocalized with activated porcine endothelial cells, which showed increasing porcine vWF expression over time, as well as with immune cells (primarily macrophages and neutrophils) and hepatocytes in the xenografts. Integrative analyses indicated that ELC procedures provided hepatic support for apolipoprotein synthesis, bilirubin clearance, energy metabolism and detoxification, although circulating lipid levels remained low under anhepatic conditions. Collectively, these findings yield insights into the complex interplay between human and xenograft systems during ELC and inform strategies to improve liver xenograft biocompatibility for clinical translation.
PMID: 42414621
ISSN: 1546-170x
CID: 6063552
Gut microbiota in a Saudi population with chronic kidney disease
Almuhanna, Afnan A; Vatte, Chittibabu; Guo, Qian; Elsalamouni, Tamer S; Al-Muhanna, Fahd A; Aboalrihy, Ameen M; Alhabib, Hassan A; Almomen, Mohammed F; Alali, Rudaynah A; Habara, Alawi H; Alrubaish, Mohammed A; Alfalah, Kaltham M; Cyrus, Cyril; Abdul-Rahman, Ibrahiem Saeed; Keating, Brendan J; Al-Ali, Amein K; Wang, Chan
BACKGROUND:The gut microbiota (GM) plays an important role in chronic kidney disease (CKD) progression, and dialysis modalities can differentially impact the GM composition and function. There is also limited information on the GM in Arab populations. AIM/OBJECTIVE:To investigate the distinct microbial profiles and functional alterations associated with hemodialysis (HD) and peritoneal dialysis (PD) in a Saudi Arabian cohort. METHODS:We performed whole-genome metagenomic sequencing on fecal samples from 189 participants (controls and CKD, HD, and PD patients). RESULTS:interactions. Conversely, the HD group showed partial recovery of microbial balance and beneficial metabolic functions, including increased short-chain fatty acid metabolism and reduced lipopolysaccharide biosynthesis. CONCLUSION/CONCLUSIONS:The findings of this study highlight the potential of the microbial profile as a robust biomarker for CKD classification and underscore the differential impacts of different dialysis modalities.
PMCID:13324665
PMID: 42395675
ISSN: 2220-6124
CID: 6063682
Author Correction: Physiology and immunology of a pig-to-human decedent kidney xenotransplant
Montgomery, Robert A; Stern, Jeffrey M; Fathi, Farshid; Suek, Nathan; Kim, Jacqueline I; Khalil, Karen; Vermette, Benjamin; Tatapudi, Vasishta S; Mattoo, Aprajita; Skolnik, Edward Y; Jaffe, Ian S; Aljabban, Imad; Eitan, Tal; Bisen, Shivani; Weldon, Elaina P; Goutaudier, Valentin; Morgand, Erwan; Mezine, Fariza; Giarraputo, Alessia; Boudhabhay, Idris; Bruneval, Patrick; Sannier, Aurelie; Breen, Kevin; Saad, Yasmeen S; Muntnich, Constanza Bay; Williams, Simon H; Zhang, Weimin; Kagermazova, Larisa; Schmauch, Eloi; Goparaju, Chandra; Dieter, Rebecca; Lawson, Nikki; Dandro, Amy; Fazio-Kroll, Ana Laura; Burdorf, Lars; Ayares, David; Lorber, Marc; Segev, Dorry; Ali, Nicole; Goldfarb, David S; Costa, Victoria; Hilbert, Timothy; Mehta, Sapna A; Herati, Ramin S; Pass, Harvey I; Wu, Ming; Boeke, Jef D; Keating, Brendan; Mangiola, Massimo; Sommer, Philip M; Loupy, Alexandre; Griesemer, Adam; Sykes, Megan
PMID: 42243534
ISSN: 1476-4687
CID: 6044562
Rare coding variation and stroke heterogeneity in Saudi Arabia: an exome‑wide association study across severity, etiology, vascular territory, and early‑onset disease
Alkhamis, Fahad; Alabdali, Majed M; Alamri, Abdullah S; Alali, Rudaynah; Habara, Alawi H; Akhtar, Mohammed S; Alkhamis, Shahad F; Rophina, Mercy; Alkhudair, Abdullah M; Vatte, Chittibabu; Keating, Brendan; Al-Ali, Amein K
BACKGROUND:Ischemic stroke in Saudi Arabia arises in a highly consanguineous population with a distinctive genetic architecture, likely enriching rare coding variants that influence stroke risk. Yet the contribution of these variants to stroke susceptibility, age at onset, and subtype patterns in this setting remains incompletely defined. METHODS:We analyzed whole-exome sequencing data from 514 stroke patients in a case only study design. Gene-based rare variant burden analyses was performed using SAIGE-GENE+ burden and SKAT-O tests across predefined phenotype contrasts within the cohort, stroke severity (modified Rankin Scale, mild < 3 vs. severe ≥ 3 ,), age at onset (early-onset < 25 years vs. late-onset > 45 years; mid-life onset < 45 vs. > 45), etiological subtypes (TOAST classification), and vascular imaging patterns (intracranial vs. extracranial).Post-association functional annotations included GTEx expression, gnomAD constraint metrics, and draggability insights. RESULTS:Gene-level associations at a suggestive threshold (p < 0.005) identified several candidates including HSP90AB1, PRR23A, and LRRC42 (severity and age-at-onset); POGZ and SMIM34 (age-at-onset); and COL9A3, DCP1B, and ADGRV1 (imaging and etiology subtypes). The highlighted genes showed varying expression across brain and vascular tissues and intolerance to loss-of-function variation. Notably, HSP90AB1, a molecular chaperone highly expressed in the brain and vasculature, has small-molecule inhibitors, supporting its potential relevance to stroke biology. CONCLUSIONS:Our findings identify exploratory candidate gene-level signals across clinically defined ischemic stroke phenotypes based on case-only within-cohort comparisons, in underrepresented population. These results should be considered hypothesis-generating and require replication and functional validation before biological or clinical inferences can be made.
PMID: 42087103
ISSN: 1471-2377
CID: 6031152
Remodeling of the circRNA Landscape in Myocardial Infarction Integrates Nuclear Regulation, DNA Damage Response, and Cardiomyocyte Structural Pathways
Alali, Rudaynah; Alqannas, Naif Khalid; Habara, Alawi H; Almansori, Mohammed; Alsaeed, Ali; Vatte, Chittibabu; Cyrus, Cyril; Alqatari, Safi G; Albisher, Hassan; Al-Ajwad, Mustafa H; Alshahrani, Faisal S; Almuslim, Moyad M; Venø, Morten T; Keating, Brendan J; Al-Ali, Amein K
Plasma circular RNAs (circRNAs) are stable RNA molecules found in blood, which makes them potential noninvasive biomarkers for acute myocardial infarction (MI). The aim of this study was to describe the plasma circRNA profile in patients with acute MI and to identify circRNA markers that may help detect heart injury and reflect the biological processes involved. We compared plasma samples from patients with acute MI and healthy controls using total RNA sequencing with unique molecular identifiers (UMIs). After sequencing, reads were processed through quality control, alignment, duplicate removal, and circRNA detection. Differential expression was analyzed after adjusting for age, sex, smoking, and technical factors. Several circRNAs were significantly different between MI cases and controls and were able to separate the two groups in principal component and receiver operating characteristic analyses. Among the most increased circRNAs were hsa-PASK_0004, hsa-STXBP3_0002, hsa-RCAN3_0002, and hsa-RANBP9_0044, while hsa-HIF1A_0002, hsa-SUZ12_0049, hsa-PNRC1_0001, and hsa-RAB2A_0002 were decreased. Several candidates showed AUC values above 0.7. Pathway analysis linked the host genes of these circRNAs to inflammation, platelet activation, coagulation, and cardiomyocyte stress responses. Overall, these findings suggest that circulating circRNAs may serve as useful blood-based markers of MI and provide insight into the molecular changes that accompany acute MI.
PMCID:13113775
PMID: 42072699
ISSN: 2218-273x
CID: 6030732
Advancing Hope Through Science: The Inaugural Richard Slayman International Workshop on Xenotransplantation
Riella, Leonardo V; Madsen, Joren C; Pierson, Richard N; Borges, Thiago J; Sachs, David; Cooper, David; Adams, Andrew; Yamada, Kazuhiko; Sykes, Megan; Nowak, Greg; Keating, Brendan J; Tatapudi, Vasishta; Kumar, Vineeta; Larsen, Christian P; Elias, Nahel; Cosimi, A Benedict; Kimura, Shoko; Sagar, Alexander; Curtis, Mike; Legorreta, Pablo; Berglund, Erik; Ayares, David; Levan, Macey L; Williams, Winfred; Ladin, Keren; Mohiuddin, Muhammad M; Reichart, Bruno; Moazami, Nader; Cleveland, David; Griffith, Bartley; Sweet, Stuart; Giarraputo, Alessia; Avillach, Claire; Rosales, Ivy; Tector, Joe; Loupy, Alex; Montgomery, Robert A; Colvin, Robert B; Fishman, Jay A; Kawai, Tatsuo
The inaugural Richard Slayman Clinical Xenotransplantation Workshop convened >140 participants from North America, Europe, and Asia to discuss emerging advances and challenges in translating xenotransplantation from bench to bedside. This report summarized key discussions spanning kidney, heart, and liver xenotransplantation, with an emphasis on clinical readiness and future directions. Core themes included the importance of patient selection, the role of genetic editing to reduce immune incompatibility, adaptive immunosuppressive strategies, novel molecular tools for immune and infectious surveillance, and the growing recognition of innate immune activation as a barrier to long-term graft survival. The workshop highlighted decedent models as a translational bridge, the use of machine perfusion in liver xenograft applications, and progress in living recipients. Notably, 1 patient achieved 9 mo of kidney xenograft function, underscoring the feasibility of extended survival in carefully selected candidates. Perspectives from patients and families, including a reflection honoring Richard Slayman, the first living recipient of a genetically edited pig kidney, framed the scientific dialogue within the broader human impact of this emerging field. The workshop marked a pivotal moment in aligning scientific, ethical, and regulatory efforts to advance safe and equitable access to xenotransplantation.
PMID: 41700849
ISSN: 1534-6080
CID: 6004522
Publisher Correction: Physiology and immunology of a pig-to-human decedent kidney xenotransplant
Montgomery, Robert A; Stern, Jeffrey M; Fathi, Farshid; Suek, Nathan; Kim, Jacqueline I; Khalil, Karen; Vermette, Benjamin; Tatapudi, Vasishta S; Mattoo, Aprajita; Skolnik, Edward Y; Jaffe, Ian S; Aljabban, Imad; Eitan, Tal; Bisen, Shivani; Weldon, Elaina P; Goutaudier, Valentin; Morgand, Erwan; Mezine, Fariza; Giarraputo, Alessia; Boudhabhay, Idris; Bruneval, Patrick; Sannier, Aurelie; Breen, Kevin; Saad, Yasmeen S; Muntnich, Constanza Bay; Williams, Simon H; Zhang, Weimin; Kagermazova, Larisa; Schmauch, Eloi; Goparaju, Chandra; Dieter, Rebecca; Lawson, Nikki; Dandro, Amy; Fazio-Kroll, Ana Laura; Burdorf, Lars; Ayares, David; Lorber, Marc; Segev, Dorry; Ali, Nicole; Goldfarb, David S; Costa, Victoria; Hilbert, Timothy; Mehta, Sapna A; Herati, Ramin S; Pass, Harvey I; Wu, Ming; Boeke, Jef D; Keating, Brendan; Mangiola, Massimo; Sommer, Philip M; Loupy, Alexandre; Griesemer, Adam; Sykes, Megan
PMID: 41680323
ISSN: 1476-4687
CID: 6002472